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SIMULATION OF THE HUMAN LUNG

Noah D. Syroid, Volker E. Boehm, and Dwayne R. Westenskow

Departments ofBioengineering and Anesthesiology
The University of Utah
Salt Lake City, UT 84132
balance equation, also known as the Fick principle2:

Abstract
A human lung simulator was implemented using a
model based on the Fick principle. The simulator is
designed to emulate C02production and 0 2consumption
in the body and gas exchange in the lung. The
implementation consists of hardware and software to
control the flow of gases entering and leaving a ventilated
test lung. An initial test of C02production qualitatively
demonstrated that the lung simulator behaved as expected.
Since this project is in its initial stages, additional
experimentation and model refinement is necessary for the
simulator to accurately represent physiologic responses of
a human lung.

(1)

Q

where is cardiac output (liters/minute), vco1 produced is
the amount of C02 produced by tissue metabolism,

cvC02 is the mixed venous C02

(liters/minute),

concentration of the blood (blood flowing into lungs in%
volume) and

caC02

is the arterial C02 concentration of

blood flowing from the lungs(% volume). For our lung
simulator, we set the cardiac output to a known value.
Thus, we may rearrange (1) so that,

Introduction

Vco produced

Modeling and simulation are important means of
testing and validating new medical devices without
involving live subjects. Human and animal testing is
expensive. Furthermore, control of respiratory parameters
may be difficult or impossible to obtain during an
experiment on live subjects. Creating a model and a
simulation may provide the means to validate new
instrumentation with less cost and more accuracy.
With this in mind, we have created a human lung simulator
to validate prototype anesthesia instrumentation. Our
simulator is designed to model C02production and 0 2
consumption, given a value for cardiac output. Such a
simulator may be used to validate medical devices that
measure cardiac output non-invasively.
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=Q·(Cv

C02

- Ca

C02

).

( 2)

For every unit of C02produced in the tissues, there is
some amount of 02 consumed (Vol consumed ). C02

··~·:·gh··.r.~·· ~~= -~~
~
Heart.

C02 production and 0 1 consumption

Figure 1 shows a simple representation of blood flow
and gas exchange in the body. Oxygen is inspired into the
alveoli of the lungs where it diffuses across the alveolar
membrane and pulmonary capillary membrane. Likewise,
carbon dioxide diffuses from the blood in the pulmonary
capillary beds and into the alveoli. Oxygen rich blood is
pumped through the right heart and into the tissues where
metabolism consumes oxygen and produces carbon
dioxide. Thus, C02rich blood is pumped through the left
side of the heart and back into the lungs 1•
Cardiac output is related to gas exchange using a mass

Tissues

Figure 1: Gas Exchange and Blood Flow in the
Human Lung and Body.

1

production may be related to 0 2 consumption by the
respiratory exchange ratio, R, where

R=

v.

.C02 produced

v02

Lung Simulator Implementation

We use equations (2) and (3) as the foundation
for our lung simulator. The physical components of the
simulator are shown in Figure 2. Since the largest portion
of ambient air is composed ofN2 , 0 2, and C02, we use
three mass flow controllers (MFCs) to regulate the flow of
these gases from pressurized tanks into a ventilated
test/training lung (TIL). A fan inside the TIL provides
active mixing of the gases from the lung simulator and the
ventilator. A vacuum is used to pull the mixed gas from
the TIL in which the flow is regulated by the exhaust
MFC. 0 2 and C02 sensors, located in the exhaust flow,
record the concentrations of oxygen and carbon dioxide in
the lung. A microprocessor controls the flow of the MFCs
and receives input from the C02 and 0 2 sensors. A
personal computer communicates with the microprocessor
and provides the user with an interface to input cardiac
output and cv (see Figure 3).

(3)

consumed

R is a function of metabolism; the body oxidizes fats,
carbohydrates, and proteins, where Rrar. = 0.7, Rcarbohydrate =
1.0, and~= 0.8. For a healthy human, a typical value
for R is 0.8.2

Training/Test Lung

[:J

~----------------------

1
I
I

--------

COl

•

lVC0 + VC0

® _:. _ . . ,. ~

2

2

produced

v

Total•

02MFC

.
.
V02 + V02 consumed
Exhaust
MFC

Computer and
User Interface

®~:
I

1------------------------------r---------------------------------

Figure 3: Microprocessor Control and
Communication

The lung simulator uses the 0 2 and C02 sensors to
calculate the flow of oxygen

Exhaust
MFC

(V02 )

and carbon dioxide

(Vco2 ) pulled from the lung by the vacuum. The exhaust

Vacuum

flow

------------------------------------·

(VExh ) is set at a constant rate, so
(4)

Figure 2: Physical Components of the Lung
Simulator
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(5)

70~--~--~----~--~--~----.

60

where F02 and Fc02 is the fraction of 0 2 and C02
measured by the sensors in the exhaust flow. Also,

and we may solve for N2 flow going into and coming out
from the lung:
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PaC02 (mm Hg)

In order to calculate 0 2 consumption and C02
production, we assume that the content of C02 in the

mixed venous blood,

C- ,
Vco2

Figure 4 : C02 Dissociation Curve With

Hb = 15 g/dl

is constant. To compute

caco2 , we first find Paco2 , arterial partial pressure (mm
Hg), which is a function of barometric pressure,
Hg). So,

Phar

Validation of Lung Simulator

(mm

Paco2 = Fco2 · ~ar (mm Hg).

Since this project is a work in progress, we have only
begun to validate the simulator. At this time, we have
compared C02 production in the lung simulator to
measured C02 production on an anesthesia monitor. This

(8)

was achieved by comparing

Paco2 is related to caco2 by a dissociation curve. Such a

(Pa

C<l2

)

= (6.957 · Hb + 94.864) ·

C02

2

and

Pa

C02

of the

lung simulator to C02 excretion at the mouth ( Vco 2 mouth ,
Vmin) and end tidal C02 (etC02, mm Hg) by the
anesthesia monitor. Our TIL may be considered as a
single alveolus with 100% perfusion (no parallel
deadspace). Under these conditions, alveolar partial

curve is empirically derived by Capek and Roy,3 which
also requires the hemoglobin (Hb) content of blood in
grams per deciliter. So,
Ca

Vco produced ,

()
(val%). 9

pressure of C02

ln(1+0.1933·PaC02 )

(

P

4
)
''m2

is approximately equal to

Pa

.

C02

P£.0"02
is related to etC02 by:
4

This function is plotted in Figure 4.

etC02 = r. pAco2 peifused + (1- r)PAco2 unpeifused' (II)

Using equations (2) -- (9), we may define the flow of
gas into the lung,

VTotal

where r is the ratio of perfused to unperfused alveoli.4 A
single alveolus model with no dead space yields

In :

C~MFCFJow

.

V Total1n

=[•V C0 + V. C02Produced J+

etC02 = PL
"'C02

(10)

~

paC02 .

(12)

2

0 2 MFCF/ow

In addition, under steady state, vco2 mouth should also have

.

N2 MFCF/ow

,............

similar values to

Also, (1 0) computes the quantity of flow for each gas
coming into the lung, which is set by its corresponding
MFC as demonstrated in Figure 2.

vco2 produced •

To validate the parameters described in the previous
section, we induced changes in the

3

Vco produced and Pa
2

C02

by changing the set value of cardiac output. For this
validation experiment, we decreased cardiac output in one
liter/min steps from 6.0 liters/min to 1.0 liter/min. Table I
describes the times at which cardiac output was altered.
Ample time was allowed between each step change so that
the system may reach steady state. Figures 5 and 6 show
comparisons of Pa"''2 to etC02 and

VC02 mouth respectively.

in Figure 6.
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Figure 6: C02 Production in the Lung Simulator
(lung = gray "0", mouth =black "+'7,the numbers
in the plot represent the value of cardiac output at
that time

Table 1: Step Decrease in Cardiac Output

Discussion
be investigated qualitatively because there is a mismatch in
the synchronization of the data collection times. There is
some inherent delay between the response of the etC02
signal to a change in alveolar pressure, but it is not on the
order of hundreds of seconds.

2000

2500

3000

Due to the limited amount data collected for validation
of the lung simulator and difficulties with synchronization
of the data collected, no significant conclusions may be
made about the accuracy of the lung simulator at this time.
It is important to note that this test described in the
previous section does not match the physiologic response
of a human's lung. That is, even though there was a fall in
the C02 parameters for the given cardiac output values,
they may not correspond correctly for a human response.
Additional experiments using human data and comparing it
to the lung simulator data are necessary in order to evaluate
how well the lung simulator models the human respiratory
system. The initial validation tests look promising with
respect to the expected behavior of the lung simulator. All
C02 parameters fell in accordance with a decreasing step
change in cardiac output.

3500

The upward shift in etC02 (Figure 5) may be due to
different computation methods for the lung simulator and
the anesthesia monitor. For instance, the dissociation curve
that is implemented for the simulator is based on empirical
data and may not match the computation methods used by
the monitor. Examination of the anesthesia monitor's
specifications could give insight into how etC02 is
calculated.

time (seconds)

Figure 5: Arterial C02 (gray "0") and etC02
(black"+")
It is apparent from Figure 5 that both signals show a
decreasing step change that corresponds to the change in
cardiac output. The etC02 is shifted up from the PaCOl date
approximately 3 to 4 mm Hg. The synchronization error is
also apparent for the C02 production values demonstrated

Ignoring the effects of the shifted data, there are some
transient spikes for the lung simulator's C02 production
(see Figure 6). The spikes are due to step changes in
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cardiac output. The step change in cardiac output causes
an instantaneous change in

Vco produced •
1
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Pacoz decreases in response to the change, the C02
production rises to a value comparable with the C02
excreted at the mouth.
Future Development
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The current model is based on the Fick principle,
which assumes a system in steady state. Thus, the model
may yield unpredictable results to the transient responses.
Furthermore Cv-

coz

solve for

is required to be constant in order to

Vc01 in the Fick equation.

This assumption is

normally valid since there is a large buffering capacity for
C02 in the body, especially in fat and muscle. 5• 6 On the
other hand, it may not be a valid assumption for patients in
septic shock, where most of the blood is flowing to vital
organs in which do not store large quantities ofC02 •6• 7
Finally it is important to notice that the Fick equation does
not account for shunt, blood that bypasses the gas
exchange occurring in the ventilated alveoli of the lung.
Therefore, the Fick equation provides an accurate estimate
of cardiac output if shunted blood is not present. Othetwise
it measures pulmonary-capillary blood flow.
A more sophisticated model may help to account for
these assumptions. Chiari, Avanzolini, and Ursino have
proposed a sophisticated respiratory model that simulates
the transport of gases to several different compartments
including the brain, cerebral spinal fluid, tissues and the
lungs. It also accounts for shunt, has chemoreceptor
control for ventilation, and incorporates acid/base
regulation into its C02 dissociation curve8 • Such a
sophisticated model may be incorporated into our lung
simulator to improve the accuracy of the model with
respect to human respiratory system.
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